Integer Holdings (NYSE: ITGR) announced today that it has completed its purchase of Oscor — a deal that expands the capabilities of what was already one of the world’s largest medtech contract manufacturers.
Integer said the acquisition would cost $220 million when it first announced its plans in October.
Oscor is the creator and marketer of various specialized implantable cardiac pacing and neurostimulation leads, venous access systems and diagnostic catheters. Integer officials note that Oscor’s finished introducer systems, guiding sheaths and proprietary lead wire technologies give it even more exposure to higher-growth markets — including cardiac pacing, electrophysiology, neurostimulation, cardiovascular, peripheral vascular and structural heart.
Get the full story on our sister site Medical Design & Outsourcing.
